National Drug Strategy
National Drug Strategy

Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician

5.8 Major clinical issues with depression and inhalant/ solvent use

prev pageTOC |next page

Table of contents

5.8.1 Effects of inhalants/ solvents on depression

5.8.2 Interactions between inhalants/ solvents and therapeutic agents for depression

5.8.3 Management approaches to comorbid depression and inhalant/ solvent use

prev pageTOC |next page